Dr. Suneet Kukreja, M.D.
What this data tells you about Dr. Kukreja
Dr. Suneet Kukreja is a cardiovascular disease in West Palm Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kukreja performed 11,556 Medicare services across 5,454 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kukreja received a total of $4,070 from 30 pharmaceutical and/or device companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kukreja is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 1,999 | $7 | $18 |
| Hospital follow-up visit, high complexity | 1,725 | $99 | $221 |
| Hospital follow-up visit, moderate complexity | 1,720 | $65 | $152 |
| Office visit, established patient (30-39 min) | 1,144 | $95 | $225 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 1,104 | $0 | $1 |
| Initial hospital admission, high complexity | 667 | $140 | $429 |
| Electrocardiogram (EKG), 12-lead | 623 | $11 | $36 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 490 | $357 | $549 |
| Echocardiogram, transthoracic | 283 | $150 | $414 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 249 | $50 | $159 |
| Regadenoson injection (Lexiscan) for heart stress test | 248 | $41 | $106 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 245 | $356 | $939 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 153 | $32 | $42 |
| Remote patient monitoring management, 20 min/month | 144 | $39 | $51 |
| New patient office visit (45-59 min) | 126 | $127 | $347 |
| Critical care, first 30-74 min | 125 | $181 | $582 |
| Remote patient monitoring device, 30 days | 110 | $38 | $56 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 98 | $20 | $68 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 82 | $21 | $55 |
| Remote pacemaker monitoring, 90 days | 66 | $24 | $71 |
| Programming of dual lead pacemaker system | 38 | $31 | $81 |
| Ultrasound of heart with probe in esophagus, with report | 31 | $79 | $229 |
| Ultrasound of both sides of head and neck blood flow | 30 | $152 | $423 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 25 | $147 | $412 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 16 | $668 | $1,492 |
| Ultrasound of leg arteries or artery grafts | 15 | $179 | $540 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kukreja is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kukreja experienced with ekg interpretation and report?
Does Dr. Kukreja receive payments from pharmaceutical companies?
How do Dr. Kukreja's costs compare to other cardiovascular diseases in West Palm Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology